ANA antibodies ≥ 1:320 were present in 26 (81%) patients with pSS; anti-SSA in 26 (81%); anti-Ro52 in 22 (69%); and anti-SSB in 21 (66%). This evidence concerns the gene BTG3 and peeling skin syndrome.